Varian Medical Systems (VAR) SVP John W. Kuo Sells 1,327 Shares

Varian Medical Systems (NYSE:VAR) SVP John W. Kuo sold 1,327 shares of Varian Medical Systems stock in a transaction that occurred on Tuesday, May 15th. The stock was sold at an average price of $117.15, for a total transaction of $155,458.05. Following the transaction, the senior vice president now owns 30,551 shares in the company, valued at $3,579,049.65. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Varian Medical Systems stock opened at $118.27 on Friday. Varian Medical Systems has a 12 month low of $117.14 and a 12 month high of $117.89. The firm has a market cap of $10.79 billion, a PE ratio of 32.85, a P/E/G ratio of 3.28 and a beta of 0.85.

Get Varian Medical Systems alerts:

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, April 25th. The medical equipment provider reported $1.15 EPS for the quarter, beating the consensus estimate of $1.04 by $0.11. Varian Medical Systems had a net margin of 4.77% and a return on equity of 27.99%. The business had revenue of $729.90 million for the quarter, compared to analysts’ expectations of $685.86 million. During the same period in the previous year, the company posted $0.89 EPS. Varian Medical Systems’s revenue was up 10.1% on a year-over-year basis. sell-side analysts predict that Varian Medical Systems will post 4.5 earnings per share for the current year.

Several institutional investors have recently bought and sold shares of VAR. Dimensional Fund Advisors LP grew its holdings in shares of Varian Medical Systems by 1.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 316,364 shares of the medical equipment provider’s stock valued at $31,655,000 after acquiring an additional 3,291 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in shares of Varian Medical Systems by 1.1% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 459,336 shares of the medical equipment provider’s stock valued at $51,056,000 after purchasing an additional 4,786 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Varian Medical Systems by 27.3% in the 4th quarter. State of Alaska Department of Revenue now owns 38,644 shares of the medical equipment provider’s stock valued at $4,293,000 after purchasing an additional 8,280 shares during the last quarter. Catawba Capital Management VA acquired a new stake in shares of Varian Medical Systems in the 4th quarter valued at $210,000. Finally, Personal Capital Advisors Corp lifted its stake in shares of Varian Medical Systems by 22.2% in the 4th quarter. Personal Capital Advisors Corp now owns 48,015 shares of the medical equipment provider’s stock valued at $5,337,000 after purchasing an additional 8,728 shares during the last quarter. Institutional investors and hedge funds own 98.51% of the company’s stock.

Several equities analysts have weighed in on the stock. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, January 28th. Zacks Investment Research upgraded shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a research report on Monday, January 29th. Barrington Research upgraded shares of Varian Medical Systems from a “market perform” rating to an “outperform” rating and set a $130.00 price objective on the stock in a research report on Thursday, January 25th. Royal Bank of Canada set a $115.00 price objective on shares of Varian Medical Systems and gave the stock a “hold” rating in a research report on Tuesday, April 10th. Finally, ValuEngine upgraded shares of Varian Medical Systems from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $115.13.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Leave a Reply

Your email address will not be published. Required fields are marked *